These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11290868)

  • 1. Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.
    Locker GJ; Wenzel C; Schmidinger M; Gnant MF; Marosi C; Jakesz R; Zielinski CC; Steger GG
    Anticancer Drugs; 2001 Mar; 12(3):209-12. PubMed ID: 11290868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
    Murad AM
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):26-32. PubMed ID: 14768402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer.
    Rha SY; Moon YH; Jeung HC; Kim YT; Sohn JH; Yang WI; Suh CO; Kim GE; Roh JK; Chung HC
    Breast Cancer Res Treat; 2005 Apr; 90(3):215-21. PubMed ID: 15830134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II activity of gemcitabine in advanced breast cancer.
    Carmichael J; Walling J
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):77-81. PubMed ID: 8893887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
    Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced breast cancer: a phase II trial with gemcitabine.
    Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
    J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
    Tan AR; Wright GS; Thummala AR; Danso MA; Popovic L; Pluard TJ; Han HS; Vojnović Ž; Vasev N; Ma L; Richards DA; Wilks ST; Milenković D; Yang Z; Antal JM; Morris SR; O'Shaughnessy J
    Lancet Oncol; 2019 Nov; 20(11):1587-1601. PubMed ID: 31575503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II].
    Fukuoka M; Noda K; Hasegawa K; Nakajima H; Furuse K; Hirabayashi K; Hasegawa K; Ogura T; Niitani H; Taguchi T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1813-24. PubMed ID: 8937492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.
    Delord JP; Raymond E; Chaouche M; Ruffie P; Ducreux M; Faivre S; Boige V; Le Chevalier T; Rixe O; Baudin E; Pautier P; Rodier JM; Chouaki N; Escudier B; Kayitalire L; Armand JP
    Ann Oncol; 2000 Jan; 11(1):73-9. PubMed ID: 10690391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer.
    Delfino C; Caccia G; Riva Gonzáles L; Mickiewicz E; Rodger J; Balbiani L; Flores Morales D; Zori Comba A; Brosio C
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):22-5. PubMed ID: 14768401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer.
    Iaffaioli RV; Tortoriello A; Santangelo M; Turitto G; Libutti M; Benassai G; Frattolillo A; Ciccarelli PD; De Rosa P; Crovella F; Carbone I; Barbarisi A
    Clin Oncol (R Coll Radiol); 2000; 12(4):251-5. PubMed ID: 11005695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine in advanced breast cancer.
    Possinger K
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():55-9. PubMed ID: 8718426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study.
    Takao S; Tokuda Y; Saeki T; Funai J; Ishii M; Takashima S
    Breast Cancer; 2012 Oct; 19(4):335-42. PubMed ID: 21751001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.
    Cortesi E; Ramponi S; Corona M; Moscetti L; Grifalchi F; Oliva A; Lembo A; Gasperoni S; Padovani A
    Lung Cancer; 2001; 31(2-3):271-6. PubMed ID: 11165407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
    Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino GR; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
    Ann Oncol; 2000 Mar; 11(3):367-71. PubMed ID: 10811508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
    Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
    Cancer Chemother Pharmacol; 1998; 41(3):217-22. PubMed ID: 9443638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal cholestatic liver failure associated with gemcitabine therapy.
    Robinson K; Lambiase L; Li J; Monteiro C; Schiff M
    Dig Dis Sci; 2003 Sep; 48(9):1804-8. PubMed ID: 14561005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
    Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
    Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.
    Vici P; Capomolla E; Foggi P; Carpano S; Conti F; Paoletti G; Cauchi C; Giacinti L; Leonetti C; Giannarelli D; Lopez M
    J Exp Clin Cancer Res; 2006 Mar; 25(1):39-44. PubMed ID: 16761616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.